A detailed history of Bryn Mawr Trust CO transactions in Insulet Corp stock. As of the latest transaction made, Bryn Mawr Trust CO holds 250 shares of PODD stock, worth $83,175. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250
Previous 503 50.3%
Holding current value
$83,175
Previous $155,000 50.32%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 20, 2025

SELL
$277.3 - $352.82 $70,156 - $89,263
-253 Reduced 50.3%
250 $77,000
Q3 2025

Oct 28, 2025

BUY
$277.3 - $352.82 $554 - $705
2 Added 0.4%
503 $155,000
Q2 2025

Jul 28, 2025

SELL
$238.57 - $327.47 $98,529 - $135,245
-413 Reduced 45.19%
501 $157,000
Q1 2025

May 08, 2025

BUY
$237.06 - $288.29 $89,134 - $108,397
376 Added 69.89%
914 $240,000
Q4 2024

Jan 28, 2025

BUY
$227.79 - $275.7 $10,706 - $12,957
47 Added 9.57%
538 $140,000
Q3 2024

Nov 25, 2024

BUY
$180.69 - $239.01 $88,718 - $117,353
491 New
491 $114,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $23.1B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Bryn Mawr Trust CO Portfolio

Follow Bryn Mawr Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.